CMND
Income statement / Annual
Last year (2025), Clearmind Medicine Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Clearmind Medicine Inc's net income was -$3.86 M.
See Clearmind Medicine Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
10/31/2025 |
10/31/2024 |
10/31/2023 |
10/31/2022 |
10/31/2021 |
10/31/2020 |
10/31/2019 |
10/31/2018 |
10/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$49.36 K
|
$71.09 K
|
$79.06 K
|
$119.62 K
|
$2.53 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$49.36 K
|
-$71.09 K
|
-$79.06 K
|
-$119.62 K
|
-$2.53 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$2.05 M
|
$1.91 M
|
$2.11 M
|
$4.42 M
|
$635.40 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.57 M
|
$6.02 M
|
$6.48 M
|
$4.47 M
|
$2.98 M
|
$230.12 K
|
$104.15 K
|
$259.19 K
|
$6.53 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$5.62 M
|
$7.93 M
|
$8.59 M
|
$8.88 M
|
$3.61 M
|
$230.12 K
|
$104.15 K
|
$259.19 K
|
$6.53 K
|
| Cost And Expenses |
$5.67 M
|
$8.00 M
|
$8.67 M
|
$9.00 M
|
$3.61 M
|
$230.12 K
|
$104.15 K
|
$259.19 K
|
$6.53 K
|
| Interest Income |
$132.90 K
|
$377.54 K
|
$81.35 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$19.54 K
|
$50.34 K
|
$0.00
|
$20.76 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$49.36 K
|
$71.09 K
|
$79.06 K
|
$119.62 K
|
$2.53 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| EBITDA |
-$3.72 M |
-$6.67 M |
-$11.75 M |
-$9.75 M |
-$3.65 M |
-$230.12 K |
-$104.15 K |
-$198.10 K |
-$6.53 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.88 M
|
$1.21 M
|
-$3.16 M
|
-$883.54 K
|
-$42.78 K
|
$0.00
|
$0.00
|
$61.10 K
|
$0.00
|
| Income Before Tax |
-$3.79 M
|
-$6.79 M
|
-$11.83 M
|
-$9.89 M
|
-$3.66 M
|
-$230.12 K
|
-$104.15 K
|
-$198.09 K
|
-$6.53 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$70.44 K
|
$526.13 K
|
$23.88 K
|
$42.99 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$3.86 M
|
-$7.31 M
|
-$11.85 M
|
-$9.93 M
|
-$3.66 M
|
-$230.12 K
|
-$104.15 K
|
-$198.09 K
|
-$6.53 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-30.34 |
-94.38 |
-2341.32 |
-9164.43 |
-4731.05 |
-507.6 |
-337.61 |
-735.01 |
-21.49 |
| EPS Diluted |
-30.34 |
-94.38 |
-2341.32 |
-9164.43 |
-4731.05 |
-507.6 |
-337.61 |
-735.01 |
-21.49 |
| Weighted Average Shares Out |
$127.09 K
|
$77.50 K
|
$5.06 K
|
$1.08 K
|
$772.79
|
$453.25
|
$308.33
|
$269.49
|
$305.56
|
| Weighted Average Shares Out Diluted |
$127.09 K
|
$77.50 K
|
$5.06 K
|
$1.08 K
|
$772.79
|
$453.25
|
$308.33
|
$269.49
|
$305.56
|
| Link |
|
|
|
|
|
|
|
|
|
